Complete Filing Data
ALR Technologies SG Ltd. reported Stockholders Equity of -$36.22 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ALR Technologies SG Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Selling General And Administrative Expense | $2.0M | $2.6M | $2.9M | $1.6M | $1.4M |
| Research And Development Expense | $883.9K | $1.4M | $482.1K | $499.0K | $1.4M |
| Net Income Loss | -$15.9M | -$7.5M | -$10.6M | -$8.4M | -$5.9M |
| Revenues | $25.5K | $2.4K | $7.5K | ||
| Operating Expenses | $3.4M | $4.8M | $4.3M | $2.9M | |
| Cost Of Revenue | $22.1K | $1.2K | $2.5K | ||
| Gross Profit | $3.4K | $1.2K | $4.9K | ||
| Other Comprehensive Income Loss Before Tax | -$7.5M | -$10.6M | -$8.5M | -$5.9M | |
| Interest Expense | $2.5M | $6.4M | $5.5M | $2.1M | |
| Sharebased Compensationselling General And Administrative | $1.4M | $1.5M | $586.5K | ||
| Nonoperating Income Expense | -$12.5M | -$2.7M | -$6.4M | ||
| Noncash Imputed Interest Expenses | $34.4K | $104.5K | $112.3K | ||
| Interest Expense Nonoperating | $12.4M | $2.5M | $6.4M | ||
| Comprehensive Income Net Of Tax | -$15.9M | -$7.5M | -$10.6M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | -$36.2M | -$31.9M | -$28.6M | -$24.3M | -$21.8M | -$31.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $40.7K | $59.1K | $148.6K | $115.9K | $66.2K | $1.8K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$18.4K | -$89.5K | $32.7K | $49.7K | $64.4K | |
| Retained Earnings Accumulated Deficit | -$136.0M | -$120.1M | -$112.6M | -$102.0M | ||
| Liabilities And Stockholders Equity | $79.5K | $155.2K | $377.3K | $193.2K | ||
| Liabilities | $36.3M | $32.1M | $28.9M | $24.5M | ||
| Interest Payable Current | $3.5M | $3.3M | $4.7M | $4.1M | ||
| Common Stock Value | $31.3M | $30.9M | $28.0M | $27.7M | ||
| Assets | $79.5K | $155.2K | $377.3K | $193.2K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$844.00 | -$844.00 | $6.1K | -$11.4K | ||
| Accounts Payable And Accrued Liabilities Current | $2.0M | $1.5M | $1.3M | $1.1M | ||
| Notes Payable Related Parties Classified Current Two | $4.2M | $3.1M | $3.1M | |||
| Notes Payable Current | $2.2M | $2.2M | $2.2M | |||
| Loans Payable Current | $2.4M | $2.2M | $1.8M | |||
| Stock Issued During Period Value Purchase Of Assets | $32.5K | $34.4K | $104.5K | |||
| Liabilities Current | $32.1M | $27.1M | $24.5M | |||
| Inventory Net | $10.9K | $11.0K | ||||
| Gains Losses On Extinguishment Of Debt | $257.7K | $310.6K | $496.1K | |||
| Accrued Interest Borrowing Costs And Interest Accretion On Loans Payable | $307.8K | $309.7K | $96.1K | |||
| Repayments Of Notes Payable | $649.7K | |||||
| Loss On Settlement Of Debt | -$139.0K | -$33.6K | ||||
| Interest Accretion On Loan Payable | $48.0K | $23.3K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.5M | -$1.6M | -$2.6M | -$2.2M | -$968.6K |
| Net Cash Provided By Used In Financing Activities | $1.5M | $1.5M | $2.5M | $2.3M | $1.0M |
| Increase Decrease In Prepaid Expense | -$16.1K | -$201.6K | $151.4K | -$14.6K | -$62.7K |
| Increase Decrease In Interest Payable Net | $203.3K | $217.3K | $218.2K | $527.3K | $528.9K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $477.7K | $452.5K | $337.3K | $211.0K | $72.1K |
| Proceeds From Issuance Of Common Stock | $744.7K | $25.00 | $1.1M | $12.1K | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$7.0K | $99.1K | -$11.4K | ||
| Share Based Compensation Professional Fees | $403.9K | $38.6K | $169.4K | $741.6K | |
| Share Based Compensation Product Development Costs | $1.1M | $227.3K | $222.2K | $1.2M | |
| Proceeds From Repayments Of Lines Of Credit | $794.5K | $728.0K | $1.1M | $820.8K | |
| Proceeds From Notes Payable | $1.1M | $649.7K | |||
| Employee Benefits And Share Based Compensation Noncash | $11.5M | $2.9M | $5.8M | $20.0K | |
| Share Based Compensation | $4.0M | $3.4M | |||
| Proceeds From Lines Of Credit | $427.8K | $794.5K | $728.0K | ||
| Increase Decrease In Other Operating Capital Net | $328.2K | $314.1K | $324.6K | ||
| Increase Decrease In Inventories | -$137.00 | $11.0K | |||
| Proceeds From Repayments Of Notes Payable | $1.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted | 581.0M | 548.1M | 535.0M | 337.0M | |
| Loss Per Share Basic And Diluted | $-0.01 | $-0.02 | $-0.02 | $-0.02 | |
| Weighted Average Number Of Shares Outstanding Basic | 598.9M | 581.0M | 548.1M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 598.9M | 581.0M | 548.1M | ||
| Earnings Per Share Diluted | $-0.03 | $-0.01 | $-0.02 | ||
| Earnings Per Share Basic | $-0.03 | $-0.01 | $-0.02 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Professional Fees | $512.6K | $814.7K | $920.2K | $881.0K | $953.4K |
| Paid In Kind Interest | $1.7M | $1.6M | $1.6M | $1.4M | $1.5M |
| Income Loss Attributable To Parent | -$3.4M | -$4.8M | -$4.3M | -$2.9M | -$3.8M |
| Stock Issued During Period Value New Issues | $744.7K | $25.00 | $1.1M | $12.1K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $11.5M | $2.9M | $5.8M | $4.4M | $2.8M |
| Net Loss | -$7.5M | -$10.6M | -$8.4M | -$8.4M | |
| Prepaid Expense Current | $28.0K | $44.0K | $228.7K | $77.3K | |
| Lines Of Credit Current | $19.9M | $18.0M | $15.8M | $14.0M | |
| Additional Paid In Capital | $68.5M | $57.3M | $56.0M | $50.0M | |
| Other Items Amount | -$2.7M | -$6.4M | -$5.5M | -$2.1M | |
| Imputed Interest | $34.4K | $104.5K | $112.3K | $123.5K | |
| Repayments Of Lines Of Credit | $310.6K | $496.1K | $456.7K | ||
| Exchange Difference On Translating Foreign Operations | -$7.0K | $17.6K | -$11.4K | ||
| Stock Issued During Period Value Stock Options Exercised | $75.0K | $12.0K | |||
| Gain Loss Related To Litigation Settlement | -$139.0K | $33.6K | |||
| Stock Issued During Period Value Conversion Of Convertible Securities | $370.0K | $250.8K | $12.1M | ||
| Noncash Contribution Expense | $32.5K | $34.4K | $104.5K | ||
| Stock Issued During Period Value Other | -$7.0K | $17.6K | $200.0K | ||
| Stock Issued During Period Value Conversion Of Units | $6.0K | $24.0K |
Most recent annual filing with the SEC: May 1, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.